J&J’s Purchase of Takeda’s Surgical Patch Subject to EU Investigation; Expect a Deal Anyways
In May 2019, Japan’s biggest drugmaker, Takeda announced the sale of its surgical patch product, TachoSil to Johnson & Johnson’s subsidiary...
542 Views
InnoCare Pharma IPO Initiation: Promising Prognosis
InnoCare Pharma Ltd (1576300D CH) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...
526 Views
Akesobio (康方生物) Pre-IPO: Late in the PD-1 Game but Products Are Promising
Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...
780 Views
Merries Baby Diaper Business: Struggles to Continue Despite Company Remarks a Quick Turnaround
Kao is a well-known Japanese conglomerate involved in various business activities ranging from FMCG products to chemicals. The company operates in...
694 Views
Mabpharm IPO Preview: Mixed Prospects of Phase 3 Drug Candidates
MabPharm (2181 HK) is a pre-revenue biopharmaceutical company in China with a focus on drugs and biosimilars for cancers and autoimmune diseases....
715 Views